» Articles » PMID: 19969084

Chronic Expression of Low Levels of Tumor Necrosis Factor-alpha in the Substantia Nigra Elicits Progressive Neurodegeneration, Delayed Motor Symptoms and Microglia/macrophage Activation

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2009 Dec 9
PMID 19969084
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation, and in particular microglia activation, is regarded as a constant component of brain pathology in Parkinson's disease (PD). Microglial activation has been found in the substantia nigra (SN), one of the main brain regions affected in PD, for many years after the initiation of the disease. Although many studies point towards a deleterious role of inflammation on PD, the functional role of many of its main components has not been clarified yet. For example, tumor necrosis factor-alpha (TNF-alpha), a key pro-inflammatory cytokine, has been shown to exert toxic or no effects on the viability of dopaminergic neurons. No study has evaluated the effects of the long-lasting TNF-alpha expression in the SN, an experimental set-up most probably resembling the clinical situation. The aim of this study was to investigate the effects of the chronic expression of TNF-alpha in the adult SN at different time points. Adenoviral expression of low TNF-alpha levels (17-19 pg/mg) lasted for 14 days in the SN and did not induce interleukin-1beta (IL-1beta) expression. Long-lasting TNF-alpha expression caused dopaminergic cell death from day 14, increasing at 21 and 28 days compared with control animals injected with adenovectors expressing beta-galactosidase. TNF-alpha overexpression elicited irreversible, unilateral akinesia starting at 14 days, but not earlier. These effects were accompanied by microglial activation to stage 4 and/or monocyte/macrophage recruitment from the periphery from day 7 post adenovector inoculations. Thus, we conclude that extended duration of the expression of TNF-alpha is necessary and sufficient for a univocal toxic effect of TNF-alpha on dopaminergic neurons and motor disabilities. This study provides an animal model to study early events that lead to TNF-alpha-mediated neuronal demise in the SN. In addition, the cellular components of the inflammation elicited by TNF-alpha and the lack of IL-1beta expression support the growing idea of a distinct cytokine network in the brain.

Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


The Dual Role of Survival Genes in Neurons and Cancer Cells: a Strategic Clinical Application of DX2 in Neurodegenerative Diseases and Cancer.

Baek K Biomol Ther (Seoul). 2024; 33(1):75-85.

PMID: 39711064 PMC: 11704411. DOI: 10.4062/biomolther.2024.138.


Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson's disease.

Zhang X, Yu H, Feng J Front Aging Neurosci. 2024; 16:1411104.

PMID: 39444806 PMC: 11496080. DOI: 10.3389/fnagi.2024.1411104.


Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects.

Sadowski K, Zajac W, Milanowski L, Koziorowski D, Figura M Int J Mol Sci. 2024; 25(14).

PMID: 39062985 PMC: 11277532. DOI: 10.3390/ijms25147741.


Neuroprotective effects of dantrolene in neurodegenerative disease: Role of inhibition of pathological inflammation.

Zhang W, Zhao X, Bhuiyan P, Liu H, Wei H J Anesth Transl Med. 2024; 3(2):27-35.

PMID: 38826587 PMC: 11138240. DOI: 10.1016/j.jatmed.2024.04.002.